These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 36847011)
21. Externalizing Behaviors and Alzheimer's Disease and Any Dementia: A Multigeneration Cohort Study in Sweden. Solares C; Zhang L; Chang Z; Andershed H; Persson J; Larsson H Innov Aging; 2023; 7(9):igad117. PubMed ID: 38024330 [TBL] [Abstract][Full Text] [Related]
22. Graves disease is associated with increased risk of clinical Alzheimer's disease: evidence from the Medicare system. Yashkin AP; Kolpakov S; Ukraintseva S; Yashin A; Akushevich I Clin Diabetes Endocrinol; 2024 Feb; 10(1):11. PubMed ID: 38317215 [TBL] [Abstract][Full Text] [Related]
23. Depressive Symptomatology as a Predictor of Cognitive Impairment: Evidence from the Korean Longitudinal Study of Aging (KLOSA), 2006-2020. Baek SU; Yoon JH Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893087 [TBL] [Abstract][Full Text] [Related]
24. Graves Disease is Associated with Increased Risk of Clinical Alzheimer's Disease: Evidence from the Medicare System. Yashkin AP; Kolpakov S; Ukraintseva S; Yashin A; Akushevich I Res Sq; 2023 Oct; ():. PubMed ID: 37886578 [TBL] [Abstract][Full Text] [Related]
25. WITHDRAWN: Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer's Disease. Villalba AC; García J; Ramos C; Cuastumal AR; Aguillón D; Aguirre-Acevedo DC; Madrigal L; Lopera F J Alzheimers Dis; 2019 Jul; ():. PubMed ID: 31381509 [TBL] [Abstract][Full Text] [Related]
26. Correction to "CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk". Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38923157 [No Abstract] [Full Text] [Related]
27. Changing profiles of the burden of Alzheimer's disease and other dementias attributable to smoking in the belt and road initiative countries: A secondary analysis of global burden of disease 2019. Luo Z; He X; Lv H; Wang Q; Jia W; Zhao Y; Li X; Yu J; Hao H; Bao Y; Chen N; Li X Heliyon; 2024 Mar; 10(6):e27935. PubMed ID: 38515688 [TBL] [Abstract][Full Text] [Related]
28. The mediating effect of Wang B; Cui C; Chen Y; Liang Z Front Aging Neurosci; 2024; 16():1328143. PubMed ID: 38511197 [TBL] [Abstract][Full Text] [Related]
30. Differences in Selective Attention and Inhibitory Control in Patients with Major Depressive Disorder and Healthy Controls Who Do Not Engage in Sufficient Physical Activity. Gerber M; Cody R; Beck J; Brand S; Donath L; Eckert A; Faude O; Hatzinger M; Imboden C; Kreppke JN; Lang UE; Mans S; Mikoteit T; Oswald A; Schweinfurth-Keck N; Zahner L; Ludyga S J Clin Med; 2023 May; 12(10):. PubMed ID: 37240475 [TBL] [Abstract][Full Text] [Related]
31. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers. Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373 [TBL] [Abstract][Full Text] [Related]